Secreted protein HHTLF25 antibodies
    91.
    发明授权
    Secreted protein HHTLF25 antibodies 失效
    分泌蛋白HHTLF25抗体

    公开(公告)号:US07105644B2

    公开(公告)日:2006-09-12

    申请号:US09983802

    申请日:2001-10-25

    IPC分类号: C07K16/24 C12N5/12 G01N33/53

    摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins. Disclosed embodiments of the invention also include antibodies that bind to secreted protein HHTLF25 and methods for making and using such antibodies.

    摘要翻译: 本发明涉及新型人分泌蛋白质和含有编码这种蛋白质的编码区基因的分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的病症的诊断和治疗方法。 本发明的公开的实施方案还包括结合分泌蛋白HHTLF25的抗体以及制备和使用该抗体的方法。

    Peptidoglycan recognition proteins
    92.
    发明授权
    Peptidoglycan recognition proteins 失效
    肽聚糖识别蛋白

    公开(公告)号:US07041802B2

    公开(公告)日:2006-05-09

    申请号:US10180454

    申请日:2002-06-27

    CPC分类号: C07K14/47 A61K38/00

    摘要: The present invention relates to three novel peptidoglycan recognition binding proteins expressed by keratinocytes, wound-healing tissues and chondrosarcoma tissue. More specifically, isolated nucleic acid molecules are provided encoding human peptidoglycan recognition protein-related proteins, referred to herein as PGRP-K (Keratinocytes), PGRP-W (Wound-healing), and PGRP-C (Chondrosarcoma) of FIGS. 1A–B, FIGS. 2A–C, and FIG. 3, respectively, each having homology to both human peptidoglycan recognition protein (PGRP) as well as murine Tag-7. PGRP-K, PGRP-W, and PGRP-C polypeptides are also provided. Further provided are vectors, host cells and recombinant methods for producing the same. The invention also relates to both the inhibition and enhancement of activities of PGRP-K, PGRP-W, and PGRP-c polypeptides and diagnostic methods for detecting PGRP-K, PGRP-W, and PGRP-C gene expression.

    摘要翻译: 本发明涉及由角质形成细胞,伤口愈合组织和软骨肉瘤组织表达的三种新的肽聚糖识别结合蛋白。 更具体地,提供分离的核酸分子,其编码人胶原聚糖识别蛋白相关蛋白(本文称为PGRP-K(角质形成细胞),PGRP-W(伤口愈合)和PGRP-C(软骨肉瘤))。 图1A-B, 图2A-C, 3,分别与人肽聚糖识别蛋白(PGRP)以及鼠Tag-7都具有同源性。 还提供了PGRP-K,PGRP-W和PGRP-C多肽。 进一步提供载体,宿主细胞和用于制备其的重组方法。 本发明还涉及PGRP-K,PGRP-W和PGRP-c多肽的活性的抑制和增强以及用于检测PGRP-K,PGRP-W和PGRP-C基因表达的诊断方法。

    Antibodies to secreted protein HEMCM42
    93.
    发明授权
    Antibodies to secreted protein HEMCM42 有权
    抗体分泌蛋白HEMCM42

    公开(公告)号:US07001992B2

    公开(公告)日:2006-02-21

    申请号:US10062831

    申请日:2002-02-05

    IPC分类号: C07K16/00

    CPC分类号: C07K14/47 A61K38/00 C07K16/00

    摘要: The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human secreted proteins.

    摘要翻译: 本发明涉及含有编码这些蛋白质的基因的编码区的新的人分泌蛋白和分离的核酸。 还提供了用于产生人分泌蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人分泌蛋白相关的病症的诊断和治疗方法。

    Vanilloid receptor-2
    95.
    发明授权
    Vanilloid receptor-2 失效
    香草素受体-2

    公开(公告)号:US06906178B2

    公开(公告)日:2005-06-14

    申请号:US10137316

    申请日:2002-05-03

    CPC分类号: C07K14/705

    摘要: The present invention relates to vanilloid receptor-2, a novel member of the vanilloid receptor family. The invention provides isolated nucleic acid molecules encoding human VR2 receptors. VR2 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of VR2 receptor activity. Also provided are diagnostic methods for detecting disease states related to the aberrant expression of VR2 receptors. Further provided are therapeutic methods for treating disease states including, but not limited to, chronic pain syndromes, congenital pain insensitivity, inflammation, ischemia, host defense dysfunction, immune surveillance dysfunction, arthritis, multiple sclerosis, autoimmunity, immune dysfunction, and allergy.

    摘要翻译: 本发明涉及香草素受体-2,其是香草素受体家族的新成员。 本发明提供编码人VR2受体的分离的核酸分子。 还提供VR2多肽,载体,宿主细胞以及用于制备它们的重组方法。 本发明还涉及鉴定VR2受体活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测与VR2受体的异常表达相关的疾病状态的诊断方法。 还提供了治疗疾病状态的治疗方法,包括但不限于慢性疼痛综合征,先天性疼痛不敏感性,炎症,缺血,宿主防御功能障碍,免疫监视功能障碍,关节炎,多发性硬化,自身免疫,免疫功能障碍和过敏。

    Nucleic acids encoding human serpin polypeptide HMCIS41
    97.
    发明授权
    Nucleic acids encoding human serpin polypeptide HMCIS41 失效
    编码人serpin多肽HMCIS41的核酸

    公开(公告)号:US06753164B2

    公开(公告)日:2004-06-22

    申请号:US09912628

    申请日:2001-07-26

    IPC分类号: C12N1512

    CPC分类号: C07K14/8121 A61K38/00

    摘要: The present invention relates to novel human Serpin polypeptides and isolated nucleic acids containing the coding regions of the genes encoding such polypeptides. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human Serpin polypeptides. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to these novel human Serpin polypeptides.

    摘要翻译: 本发明涉及新的人Serpin多肽和含有编码这些多肽的基因的编码区的分离的核酸。 还提供了用于产生人Serpin多肽的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与这些新型人Serpin多肽相关的疾病的诊断和治疗方法。

    Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
    98.
    发明授权
    Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) 失效
    使用人G蛋白趋化因子受体HDGNR10(CCR5)进行筛选的方法

    公开(公告)号:US06743594B1

    公开(公告)日:2004-06-01

    申请号:US09502784

    申请日:2000-02-11

    申请人: Yi Li Steven M. Ruben

    发明人: Yi Li Steven M. Ruben

    IPC分类号: G01N33567

    摘要: Human G-protein chemokine receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the G-protein chemokine receptor polypeptides, respectively. Also disclosed are diagnostic methods for detecting a mutation in the G-protein chemokine receptor nucleic acid sequences and detecting a level of the soluble form of the receptors in a sample derived from a host.

    摘要翻译: 公开了人G-蛋白趋化因子受体多肽和编码这种多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这些多肽来鉴定此类多肽的拮抗剂和激动剂的方法,以及分别在治疗上使用激动剂和拮抗剂治疗与G蛋白趋化因子受体多肽的低表达和过表达有关的病症的方法。 还公开了用于检测G蛋白趋化因子受体核酸序列中的突变并检测衍生自宿主的样品中受体的可溶形式的水平的诊断方法。

    T1 receptor-like ligand II polypeptides
    99.
    发明授权
    T1 receptor-like ligand II polypeptides 失效
    T1受体样配体II多肽

    公开(公告)号:US06667032B2

    公开(公告)日:2003-12-23

    申请号:US09317641

    申请日:1999-05-25

    IPC分类号: A61K4500

    CPC分类号: C07K14/54

    摘要: The present invention concerns a novel T1R-like ligand II protein. In particular, isolated nucleic acid molecules are provided encoding the T1R-like ligand II protein. T1R-like ligand II polypeptides are also provided, as are recombinant vectors and host cells for expressing the same.

    摘要翻译: 本发明涉及一种新的T1R样配体II蛋白。 特别地,提供编码T1R样配体II蛋白质的分离的核酸分子。 还提供了T1R样配体II多肽,重组载体和用于表达它们的宿主细胞也是如此。